Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiol Oncol. 2023;57(3):405-410. Accessed September 23, 2026. https://www.radioloncol.com/index.php/ro/article/view/4122